Epstein–Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin

Seung Ju Kim(University of Nebraska–Lincoln), Woo Seob Kim(Samsung Medical Center), Young Hyeh Ko(Cheju Halla General Hospital), Chang‐Seok Ki(Green Cross (South Korea)), Jin Sung Kim(Yonsei University), Jae‐Hun Kim(Yonsei University)
Annals of Oncology
December 10, 2015
Cited by 69


Related Papers